<DOC>
	<DOCNO>NCT00354432</DOCNO>
	<brief_summary>RATIONALE : Soy protein/isoflavones venlafaxine may help relieve hot flash patient receive hormone therapy prostate cancer . It yet know whether soy protein/isoflavones effective venlafaxine give together placebo treat hot flash . PURPOSE : This randomized phase III trial study soy protein/isoflavones venlafaxine compare well work give together placebo treat hot flash patient receive hormone therapy prostate cancer .</brief_summary>
	<brief_title>Soy Protein/Isoflavones Venlafaxine Treating Hot Flashes Patients Receiving Hormone Therapy Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Assess effect soy protein/isoflavones venlafaxine hot flash symptom severity score patient undergoing hormonal manipulation treatment prostate cancer . Secondary - Assess effect soy protein/isoflavones venlafaxine quality life patient . - Monitor assess participant drop rate . OUTLINE : This randomize , double-blind , multicenter study . Patients stratify accord severity disease ( metastatic v nonmetastatic ) baseline severity hot flash . Patients randomize 1 4 treatment arm . - Arm I : Patients receive oral placebo pill oral soy protein/isoflavones powder daily . - Arm II : Patients receive oral venlafaxine oral placebo powder daily . - Arm III : Patients receive oral venlafaxine oral soy protein/isoflavones powder daily . - Arm IV : Patients receive oral placebo pill oral placebo powder daily . Treatment arm continue 12 week absence disease progression unacceptable toxicity . After 12 week treatment , patient arm I III receive taper dose oral venlafaxine daily 1 week . Patients complete vasomotor symptom diary daily begin 7 day initiation study treatment continue completion study treatment . Quality life assess baseline week 12 . PROJECTED ACCRUAL : A total 176 patient accrue study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm prostate cancer Any stage disease allow Undergoing underwent androgen deprivation treatment control prostate cancer include follow : Bilateral orchiectomy Luteinizing hormonereleasing hormone ( LHRH ) agonist therapy ( e.g. , leuprolide , goserelin , bicalutamide , flutamide , similar agent ) without antiandrogen therapy Chemotherapy Radiotherapy ( patient may undergo concurrent radiotherapy prostate , prostate seminal vesicle , and/or pelvis ) Seed implant allow Hot flash frequency ≥ 4 per day , define sweating , flushing , sensation warmth , night sweat Hot flash must moderate ( grade 2 ) severe ( grade 3 ) Patient report overall hot flash severity moderate severe PATIENT CHARACTERISTICS : Life expectancy ≥ 9 month Bilirubin &lt; 2 mg/dL AST ≤ 2 time normal Must telephone No allergy soy dairy product No uncontrolled hypertension ( i.e. , BP 160/90 mm Hg ) American Heart Association functional capacity ≥ class I No history mania , hypomania , bipolar disorder , anorexia nervosa No history seizures No history hepatic dysfunction No history intolerance venlafaxine No history seizure disorder PRIOR CONCURRENT THERAPY : See Disease Characteristics More 14 day since prior venlafaxine , monoamine oxidase inhibitor ( MAOI ) , selective serotonin reuptake inhibitor ( SSRI ) , selective norepinephrine reuptake inhibitor ( SNRI ) Prior concurrent stable regimen soy food , soy base supplement allow Concurrent stable regimen herbal supplement hot flash allow No concurrent chemotherapy , radiotherapy , surgery No concurrent estrogen , progestational agent , corticosteroid , androgen , medication ( clonidine bellamine ) direct alleviate hot flash No concurrent SSRIs , SNRIs , MAOIs , linezolide No concurrent medication relieve hot flash No concurrent antidepressant therapy</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>hot flash</keyword>
</DOC>